tadalafil has been researched along with Carcinogenesis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aldosary, S; Ansari, MN; Kaithwas, G; Kasna, S; Roy, S; Saeedan, AS; Singh, M | 1 |
| Aversa, A; Bimonte, VM; Fittipaldi, S; Francomano, D; Greco, EA; Lenzi, A; Migliaccio, S; Papa, V; Wannenes, F | 1 |
2 other study(ies) available for tadalafil and Carcinogenesis
| Article | Year |
|---|---|
Repurposing mechanistic insight of PDE-5 inhibitor in cancer chemoprevention through mitochondrial-oxidative stress intervention and blockade of DuCLOX signalling.
Topics: Animals; Apoptosis; Carcinogenesis; Caspase 3; Caspase 8; Female; Heart Rate; Inflammation Mediators; Lipoxygenase; Mammary Neoplasms, Experimental; Methylnitrosourea; Mitochondria; Oxidative Stress; Phosphodiesterase 5 Inhibitors; Prostaglandin-Endoperoxide Synthases; Rats; Rats, Wistar; Reactive Oxygen Species; Signal Transduction; Tadalafil | 2019 |
Tadalafil modulates aromatase activity and androgen receptor expression in a human osteoblastic cell in vitro model.
Topics: Aromatase; Carcinogenesis; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cyclic Nucleotide Phosphodiesterases, Type 5; Down-Regulation; Enzyme Repression; Estrogen Receptor alpha; Humans; Osmolar Concentration; Osteoblasts; Phosphodiesterase 5 Inhibitors; Receptors, Androgen; RNA, Messenger; Tadalafil; Testosterone; Up-Regulation | 2016 |